Follow
Afsaneh Shirani, MD, MSCI
Afsaneh Shirani, MD, MSCI
Verified email at unmc.edu
Title
Cited by
Cited by
Year
Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis
A Shirani, Y Zhao, ME Karim, C Evans, E Kingwell, ML Van Der Kop, ...
Jama 308 (3), 247-256, 2012
3452012
Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada
E Kingwell, M Van der Kop, Y Zhao, A Shirani, F Zhu, J Oger, H Tremlett
Journal of Neurology, Neurosurgery & Psychiatry 83 (1), 61-66, 2012
2182012
Outcomes and recurrence rates in chronic subdural haematoma
A Amirjamshidi, M Abouzari, B Eftekhar, A Rashidi, J Rezaii, K Esfandiari, ...
British journal of neurosurgery 21 (3), 272-275, 2007
1472007
Characterising aggressive multiple sclerosis
S Menon, A Shirani, Y Zhao, J Oger, A Traboulsee, MS Freedman, ...
Journal of Neurology, Neurosurgery & Psychiatry 84 (11), 1192-1198, 2013
1152013
Therapeutic advances and future prospects in progressive forms of multiple sclerosis
A Shirani, DT Okuda, O Stüve
Neurotherapeutics 13 (1), 58-69, 2016
1062016
Marginal structural Cox models for estimating the association between β-interferon exposure and disease progression in a multiple sclerosis cohort
ME Karim, P Gustafson, J Petkau, Y Zhao, A Shirani, E Kingwell, C Evans, ...
American journal of epidemiology 180 (2), 160-171, 2014
842014
Antimicrobial resistance pattern of Gram-negative bacilli of nosocomial origin at 2 university hospitals in Iran
A Hadadi, M Rasoulinejad, Z Maleki, M Yonesian, A Shirani, Z Kourorian
Diagnostic microbiology and infectious disease 60 (3), 301-305, 2008
802008
Multiple sclerosis in older adults: the clinical profile and impact of interferon Beta treatment
A Shirani, Y Zhao, J Petkau, P Gustafson, ME Karim, C Evans, E Kingwell, ...
BioMed research international 2015 (1), 451912, 2015
762015
Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression
P Lourenco, A Shirani, J Saeedi, J Oger, WE Schreiber, H Tremlett
Multiple Sclerosis Journal 19 (5), 577-584, 2013
742013
Comparison of statistical approaches for dealing with immortal time bias in drug effectiveness studies
ME Karim, P Gustafson, J Petkau, H Tremlett, ...
American journal of epidemiology 184 (4), 325-335, 2016
672016
Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975–2009)
A Shirani, Y Zhao, E Kingwell, P Rieckmann, H Tremlett
Multiple Sclerosis Journal 18 (4), 442-450, 2012
662012
Evaluating the safety of β-interferons in MS: a series of nested case-control studies
HJI De Jong, E Kingwell, A Shirani, JW Cohen Tervaert, R Hupperts, ...
Neurology 88 (24), 2310-2320, 2017
572017
Beta‐interferon exposure and onset of secondary progressive multiple sclerosis
T Zhang, A Shirani, Y Zhao, ME Karim, P Gustafson, J Petkau, C Evans, ...
European Journal of Neurology 22 (6), 990-1000, 2015
472015
The effect of smoking on the symptoms and progression of multiple sclerosis: a review
A Shirani, H Tremlett
Journal of inflammation research, 115-126, 2010
402010
Adverse event profile differences between rituximab and ocrelizumab: Findings from the FDA Adverse Event Reporting Database
NG Caldito, A Shirani, A Salter, O Stuve
Multiple Sclerosis Journal 27 (7), 1066-1076, 2021
392021
Finger tapping impairments are highly sensitive for evaluating upper motor neuron lesions
A Shirani, BD Newton, DT Okuda
BMC neurology 17, 1-8, 2017
382017
Natalizumab for multiple sclerosis: a case in point for the impact of translational neuroimmunology
A Shirani, O Stüve
The Journal of Immunology 198 (4), 1381-1386, 2017
362017
Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials
Y Zhang, N Gonzalez Caldito, A Shirani, A Salter, G Cutter, W Culpepper, ...
Therapeutic Advances in Neurological Disorders 13, 1756286420969016, 2020
332020
Serum prolactin level in patients with multiple sclerosis: a case control study.
MH Harirchian, MA Sahraian, A Shirani
Medical Science Monitor: International Medical Journal of Experimental and …, 2006
312006
Disability progression in aggressive multiple sclerosis
S Menon, F Zhu, A Shirani, J Oger, MS Freedman, H Tremlett
Multiple Sclerosis Journal 23 (3), 456-463, 2017
282017
The system can't perform the operation now. Try again later.
Articles 1–20